November 12, 2025 · Form 4 insider transaction
Ragosa Mark bought 19,900 shares of Kiniksa Pharmaceuticals Ltd. at $30.93 per share, a transaction worth $615.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024.